Sun C L, Thompson T J, Hanig J P
J Pharm Pharmacol. 1984 Jun;36(6):401-3. doi: 10.1111/j.2042-7158.1984.tb04408.x.
Propranolol was infused in SHR subcutaneously for 7 days at two concentrations (either 3.75 or 7.5 mg kg-1 day) via a minipump. Mean blood pressure and heart rate measured under pentobarbitone anaesthesia on day 7 after implantation showed a significant dose-dependent decrease in both propranolol-treated groups. In the low-dose propranolol-treated rats, there was no change in contractile responses to phenylephrine over controls. In rats receiving the higher dose of propranolol there was a significant increase in the response to phenylephrine. There was no change in the relaxation response of any of the groups to isoprenaline. The results indicate that propranolol, while lowering blood pressure and heart rate, is also modifying the alpha-receptor response of the vascular wall in the spontaneously hypertensive rat.
通过微型泵以两种浓度(3.75或7.5毫克/千克/天)对自发性高血压大鼠(SHR)进行为期7天的皮下普萘洛尔输注。植入后第7天,在戊巴比妥麻醉下测量的平均血压和心率显示,两个普萘洛尔治疗组均出现显著的剂量依赖性下降。在低剂量普萘洛尔治疗的大鼠中,对去氧肾上腺素的收缩反应与对照组相比没有变化。在接受高剂量普萘洛尔的大鼠中,对去氧肾上腺素的反应显著增加。所有组对异丙肾上腺素的舒张反应均无变化。结果表明,普萘洛尔在降低血压和心率的同时,也改变了自发性高血压大鼠血管壁的α受体反应。